Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer's patients

被引:32
作者
GonzalezLima, F [1 ]
Valla, J [1 ]
MatosCollazo, S [1 ]
机构
[1] UNIV TEXAS, DEPT PSYCHOL, AUSTIN, TX 78712 USA
关键词
cytochrome oxidase; quantitative cytochemistry; inferior colliculus; morphometry; Alzheimer's disease; cellular energy metabolism;
D O I
10.1016/S0006-8993(96)01464-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Quantitative cytochemistry of cytochrome oxidase (C.O.) was implemented in human brains to measure C.O. activity in the 3 main divisions of the inferior colliculus (IC): central (ICC), dorsal (ICD), and external (ICE). Units of C.O. activity (mu mol/min/g tissue wet weight) were quantified in cellular compartments (overall average, neuropil, perikaryon, and dendrites) at the light microscope level using microdensitometry calibrated with C.O. activity standards measured spectrophotometrically. In a non-AD (Alzheimer's disease) control group (mean age = 79.6 +/- 3.1 years, postmortem time = 6.9 +/- 1.6 h), the ICC and ICD demonstrated higher (p < 0.008) overall average activities (mean = 183.40 +/- 18.7 and 184.98 +/- 45.1 units, respectively) relative to the ICE (56.46 +/- 15.9 units). Comparison of cellular morphometry (soma and nucleus area, perimeter, and diameter) revealed that the ICC contained cells of significantly larger soma size than in both the ICD and ICE (p < 0.002). The distribution of soma diameters in the TCC of controls showed a clear bimodality, enabling the typing of the cells into larger and smaller than average soma diameter. Brains from patients with Alzheimer's disease (AD; mean age = 78.3 +/- 2.9 years, postmortem time = 6.5 +/- 1.3 h) were compared with the non-AD controls. Significant group differences were found only in the large cells of the ICC. The AD large cells showed a decrement in C.O. activity relative to the corresponding controls in overall average activity (p < 0.032) and in peak activity of neuropil near the soma (p < 0.012). These findings provide the first quantitative cytochemical data of C.O. activity in humans. They also suggest that cellular alterations in C.O. metabolism in AD affect predominantly specific groups of larger projection neurons while neighboring neurons are spared. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 40 条
[1]   TECHNICAL CONSIDERATIONS ON USE OF HORSERADISH-PEROXIDASE AS A NEURONAL MARKER [J].
ADAMS, JC .
NEUROSCIENCE, 1977, 2 (01) :141-&
[2]   LOSS OF NEURONS IN THE NUCLEUS BASALIS OF MEYNERT IN ALZHEIMERS-DISEASE, PARALYSIS AGITANS AND KORSAKOFFS DISEASE [J].
ARENDT, T ;
BIGL, V ;
ARENDT, A ;
TENNSTEDT, A .
ACTA NEUROPATHOLOGICA, 1983, 61 (02) :101-108
[3]   DO DEFECTS IN MITOCHONDRIAL ENERGY-METABOLISM UNDERLIE THE PATHOLOGY OF NEURODEGENERATIVE DISEASES [J].
BEAL, MF ;
HYMAN, BT ;
KOROSHETZ, W .
TRENDS IN NEUROSCIENCES, 1993, 16 (04) :125-131
[4]  
Bennett M C, 1992, J Geriatr Psychiatry Neurol, V5, P93
[5]   CHRONIC SODIUM-AZIDE TREATMENT IMPAIRS LEARNING OF THE MORRIS WATER MAZE TASK [J].
BENNETT, MC ;
ROSE, GM .
BEHAVIORAL AND NEURAL BIOLOGY, 1992, 58 (01) :72-75
[6]   QUANTITATIVE HISTOCHEMISTRY OF ACETYLCHOLINESTERASE IN RAT AND HUMAN-BRAIN POSTMORTEM [J].
BIEGON, A ;
WOLFF, M .
JOURNAL OF NEUROSCIENCE METHODS, 1986, 16 (01) :39-45
[7]   Regional brain effects of sodium azide treatment on cytochrome oxidase activity: A quantitative histochemical study [J].
Cada, A ;
GonzalezLima, F ;
Rose, GM ;
Bennett, MC .
METABOLIC BRAIN DISEASE, 1995, 10 (04) :303-320
[8]  
CAJAL SRY, 1995, HISTOLOGY NERVOUS SY, P125
[9]   IMPAIRMENT IN MITOCHONDRIAL CYTOCHROME-OXIDASE GENE-EXPRESSION IN ALZHEIMER-DISEASE [J].
CHANDRASEKARAN, K ;
GIORDANO, T ;
BRADY, DR ;
STOLL, J ;
MARTIN, LJ ;
RAPOPORT, SI .
MOLECULAR BRAIN RESEARCH, 1994, 24 (1-4) :336-340
[10]   DIFFERENTIAL EXPRESSION OF CYTOCHROME-OXIDASE (COX) GENES IN DIFFERENT REGIONS OF MONKEY BRAIN [J].
CHANDRASEKARAN, K ;
STOLL, J ;
GIORDANO, T ;
ATACK, JR ;
MATOCHA, MF ;
BRADY, DR ;
RAPOPORT, SI .
JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 32 (03) :415-423